“Phillip Altman has expertise in the areas of clinical medical research and pharmaceutical drug regulatory affairs in Australia. Holding the degrees Bachelor of Pharmacy (Hons), and Master of Science and Doctor of Philosophy, Phillip’s doctorate concerned the development of new cardiotonic drugs with lower intrinsic toxicity, compared to existing drugs including their chemical synthesis and testing in various animal models.

Dr. Phillip Altman also founded the Association of Regulatory and Clinical Scientists (ARCS), which includes more than 2,000 scientists, clinicians, and associated health professionals involved in both clinical trial and regulatory affairs, in Australia and New Zealand.”
WORLD COUNCIL FOR HEALTH
https://worldcouncilforhealth.org/multimedia/phillip-altman-time-of-covid/